Open access · US-GOV via ClinicalTrials.gov Clinical trial

Clinical Evaluation, Biomarkers and Metabolomics of Sarcopenia in Frail Older Adults at Ambulatory Clinics

Authors not listed

National Taiwan University Hospital · 2011

Dysbiosis Human Randomized controlled trial

Abstract

Sarcopenia related mobility dysfunction was a preventable presentation in transitional variation of frailty. However, the definition, associated risk factors, clinical course and outcome of sarcopenia in Taiwanese older adults are still under-clarified and need for further study.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-12 MST

Cite this

APA

Anonymous. (2011). Clinical Evaluation, Biomarkers and Metabolomics of Sarcopenia in Frail Older Adults at Ambulatory Clinics. <em>National Taiwan University Hospital</em>. https://clinicaltrials.gov/study/NCT02073370

Vancouver

Anonymous. Clinical Evaluation, Biomarkers and Metabolomics of Sarcopenia in Frail Older Adults at Ambulatory Clinics. National Taiwan University Hospital. 2011.

BibTeX

@misc{anon2011Clinic, title = {Clinical Evaluation, Biomarkers and Metabolomics of Sarcopenia in Frail Older Adults at Ambulatory Clinics}, author = {Anonymous}, journal = {National Taiwan University Hospital}, year = {2011}, }